What were Astec Lifesciences Ltd's latest quarterly results?
Astec Lifesciences Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +51.8%
- Revenue Growth YoY: +32.7%
- Operating Margin: 5.8%
Astec Lifesciences Ltd: Stock Analysis & Fundamentals
Updated this weekAstec Lifesciences Ltd (Pesticides/Agrochemicals) — fundamental analysis, earnings data, and key metrics. ROE: -25.2%. This stock is not currently in the Nifty 500 momentum outperformers list.
Astec Lifesciences Ltd Key Facts
What's Happening
💪Debt reduced 18% YoY — balance sheet strengthening
👔Promoter buying — stake up 5.7% this quarter
🌐FII stake decreased 0.5% this quarter
Key Numbers
Current Price
₹752
Market Cap
1.7K Cr
Valuation
N/AOther Top Pesticides/Agrochemicals Stocks Beating Nifty 500
Frequently Asked Questions: Astec Lifesciences Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Astec Lifesciences Ltd's price-to-book ratio?
Astec Lifesciences Ltd's price-to-book ratio is 4.3x.
- Price-to-Book (P/B): 4.3x
- Book Value per Share: ₹175
- Current Price: ₹752
Is Astec Lifesciences Ltd a fundamentally strong company?
Astec Lifesciences Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): -5.0%
Is Astec Lifesciences Ltd debt free?
Astec Lifesciences Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹449 Cr
What is Astec Lifesciences Ltd's return on equity (ROE) and ROCE?
Astec Lifesciences Ltd's return ratios over recent years
- FY2024: ROCE -4.0%
- FY2025: ROCE -13.0%
- FY2026: ROCE -5.0%
Is Astec Lifesciences Ltd's cash flow positive?
Astec Lifesciences Ltd's operating cash flow is negative (FY2026).
- Cash from Operations (CFO): ₹-81 Cr
- Free Cash Flow (FCF): ₹-85 Cr
What is Astec Lifesciences Ltd's dividend yield?
Astec Lifesciences Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹752
Who holds Astec Lifesciences Ltd shares — promoters, FII, DII?
Astec Lifesciences Ltd's shareholding pattern (Mar 2026)
- Promoters: 72.0%
- FII (Foreign): 0.0%
- DII (Domestic): 3.3%
- Public: 24.7%
Is promoter holding increasing or decreasing in Astec Lifesciences Ltd?
Astec Lifesciences Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 72.0% (Mar 2026)
- Previous Quarter: 72.0% (Dec 2025)
- Change: 0.00% (stable)
Is Astec Lifesciences Ltd a new momentum entry or an established outperformer?
Astec Lifesciences Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Astec Lifesciences Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Astec Lifesciences Ltd may be worth studying
- Currently showing mixed signals — monitor for clearer trend confirmation
What is the investment thesis for Astec Lifesciences Ltd?
Astec Lifesciences Ltd investment thesis summary:
What is the future outlook for Astec Lifesciences Ltd?
Astec Lifesciences Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.